Trial Profile
A Phase 3, Randomized, Double-blind, Active-controlled, Multicenter Study to Evaluate the Efficacy and Safety of a Triple Therapy With CJ-12420, Amoxicillin and Clarithromycin in H. Pylori Positive Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 09 Mar 2023
Price :
$35
*
At a glance
- Drugs Amoxicillin (Primary) ; Clarithromycin (Primary) ; Tegoprazan (Primary) ; Lansoprazole
- Indications Helicobacter pylori infections
- Focus Registrational; Therapeutic Use
- Sponsors CJ HealthCare; HK inno.N
- 20 Aug 2019 Status changed from recruiting to completed.
- 26 Nov 2017 Status changed from not yet recruiting to recruiting.
- 25 Oct 2017 New trial record